As filed · Press Release
2015, please find enclosed a copy of the Press Release on the Unaudited Consolidated Financial Results. (Formerly known as Anthem Biosciences Private Limited).
Reported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Prior statements by this company that CapitSignal has recorded changing.
Our employee cost has been amongst the lowest vis-a-vis as a percentage of sales vis-a-vis the industry, although it might look for this quarter about 18.8%, it might look higher, but that's largely on account of the muted revenue for Q1 FY27.
But if you look at on an FY27 full year basis, we will be largely around 13% sort of number as a percentage of sales.
It is the sales this time is lower quarter one and hence it reflects about 8.2%, but I think full year number trajectory will be in that 9% to 10% range.
On the margin front, we delivered year-on-year improvement across both EBITDA and PAT margins.
But if you look at on an FY27 full year basis, we will be largely around 13% sort of number as a percentage of sales.
Other expenses will also be in a similar 9% sort of the percentage of sales.
